​EARLY STAGE TECHNOLOGY MANAGEMENT CONSULTANCY SINCE 2010

Welcome to Biospire, a global innovation and technology management consultancy. We specialise in working with early stage technology projects including those developed within academic environments. We provides support and development services to a variety of clients including university technology transfer offices, research councils, large corporates, technology-based SMEs, and partnering work with other specialist consultancies.

Global Ecosystems | Open Innovation | Proactive Business Development | Technology Management

 
 
EVENTS & NEWS
  • LINK-J - Oxentia - Oxford University Innovation 共同開催プログラム Oxford Evening Series Vol.4 "Entrepreneurship"
    Zoom
OUR VALUED PARTNERS 

Collaboration matters

 
DefiniGEN 2020 logo.jfif

DefiniGEN

Cambridge, U.K.

iPS differentiation and disease modelling company. Biospire supports global business development in APAC.

Cresst Logo小_edited.png

Cresset

Cambridge, U.K.

AI drug discovery, compound designing company. Biospire support business development in Japan with playing exclusive primary contact.

logo.jpg

Afortiori

Galway, Ireland

Clinical study coordinating CRO. Biospire links to Japanese clients who requires professional designing, planning, management and reporting for European regulatory approvals.

MiCAN SQ.png

MiCAN

Kyoto, Japan

iPS-derived myeloid cell development company. Biospire support global business development including logistics partnership.

logo.png

Business Crescendo

Paris, France

Strategic and operational business development partner in Europe for high-tech businesses with having partnership with Biospire.

GRS logo SQ.png

GRS

Cambridge, U.K.

Full-service regulatory and quality compliance consultancy including MDR, IVDR, EU/UK REP supports. Our Biospire clients receive benefit of having clear regulatory advices.

 
WE ARE GLOBAL

Active multiple business locations

Tokyo, Japan

Headquarters at Nihonbashi Life Science Building (5F)

  • Inside the most active life science ecosystem (LINK-J - Nihonbashi Life Science Building)

  • Satellite function for strategic and selected UK/EU life science startups.

Oxford, U.K.

UK/EU Strategic Business Development

  • Satellite business development functions for Japanese startups and corporate

  • Touchpoint for UK/EU startup companies targeting Japan business development

  • Liaison function for Japanese ecosystems.

 

We do many and flexible, but here is a bit of our introduction

OUR CORE SERVICES

GLOBAL BUSINESS DEVELOPMENT

The development and launch of a new spin-out technology business can be a lengthy and complex process. Navigating through business planning , negotiating corporate structures and licensing deals, assembling the founding team, and securing investment requires a diverse and specialist range of knowledge and experience. Biospire has particular expertise through the entire process and we have a pragmatic and practical approach to these assignments, utilising our experience and networks to launch robust new technology businesses.

TECHNOLOGY EVALUATION

We are able to bring an independent, mature and experienced view to a developing early stage technology project. Introducing a combination of extensive technical knowledge with commercial experience to independently evaluate the science and development prospects of an emerging technology. 
This work involves critically reviewing the technology, existing and prospective intellectual property, research competitive landscape, and exploring opportunities for further improving the potential, robustness, and protection of the technology itself.

MARKET ASSESSMENT

We know that no matter how potentially revolutionary a new technology may be, market identification, positioning, perception, reaction, and rate of technology uptake are fundamental to the successful commercialisation of early stage technology. We don’t just rely on industry market research data. 
We collect first hand information direct from prospective customers and associated stakeholders to derive a clearer understanding of the potential and risks of commercialisation.

DEVELOPMENT OF SPIN-OUT COMPANIES

The development and launch of a new spin-out technology business can be a lengthy and complex process. Navigating through business planning , negotiating corporate structures and licensing deals, assembling the founding team, and securing investment requires a diverse and specialist range of knowledge and experience. Biospire has particular expertise through the entire process and we have a pragmatic and practical approach to these assignments, utilising our experience and networks to launch robust new technology businesses.

LICENSING WORK

Successful and effective IP licensing starts with clear presentation, and efficient identification of target licensees. We often work with our clients, bringing our experience in understanding and interpreting new technology platforms, to distil the opportunity to a brief and succinct profile for presentation to prospective licensees. We then utilise our direct and indirect networks to identify and engage potential licensees, and can then work with our clients to negotiate and close licensing deals as appropriate.

 
PARTNERING OPPORTUNITIES

Biospire selects high value partnering opportunities with identifying early stage technologies from the world

  • BSJ20003

    Xeno-free growth factor for cell culture

    An UK startup company having stable production of recombinant but xeno-free growth factors and cytokine is looking for Japanese users and business partners including distributors.

    UK life science startup

    Japanese distributors and users

  • BSJ20004

    iPS-derived hepatocyte for cell therapy

    An Cambridge pre-startup is looking for series-A funds for clinical trial for high-function iPS-derived hepatocytes for cell therapy application.  

    Cambridge stem cell pre-startup

    Series-A investment for clinical trial

  • BSJ20101

    GMP spray dry technology for pharma

    A Japanese chemical company having GMP complied spray drying technologies and facility is looking for partnership opportunities with global pharmaceutical companies.

    Japanese chemical company

    Global business opportunities

  • BSJ20102

    High druggable chemical compounds for DD

    A Japanese chemical major produces super high pure and druggable diverse chemical compounds and library with high frequency updating. They used to be domestic focused but now challenging global business development.

    UK life science startup

    Japanese distributors and users

  • BSJ20103

    COVID-19 optimised human myeloid cells

    A Kyoto HQ'd company having patented myeloid cell differentiation from iPSC launched cryopreserved myeloid cells suitable for COVID-19 vaccine and drug development.

    Japanese life science startup

    Global R&D partnership

  • Coming soon

    PM2.5 agglomeration ion-ion interaction

    Discovered in a university in Thailand for domestic and industrial application for safe and natural nano-particle dispersion system for daily uses. 

    Life science startup from Thailand

    Japanese distributors and users

  • Coming soon

    Nano drug carrier for nasal vaccination

    A Tokyo University startup having technology to produce safe drug delivery carrier using nano-technology is looking for a series-B investors for clinical study phase I (POC) and further.

    Japanese life science startup

    Investment opps (series B)

  • Coming soon

    Novel particle dispersion detecting technology

    Using patented magnetic susceptibility technologies, that all particle motile under super-high magnetic gradient, new methods to be able to detect particle dispersion/mixture can be detected.

    Japanese material startup

    Investment opps (series B)

 
CONTACT US